Spirepoint Private Client LLC trimmed its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 94.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,738 shares of the conglomerate's stock after selling 27,558 shares during the quarter. Spirepoint Private Client LLC's holdings in Danaher were worth $356,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of the business. Heck Capital Advisors LLC bought a new position in Danaher during the 4th quarter worth $27,000. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. Hurley Capital LLC acquired a new position in shares of Danaher in the fourth quarter worth $34,000. Rialto Wealth Management LLC acquired a new position in Danaher in the 4th quarter worth about $34,000. Finally, Dunhill Financial LLC lifted its stake in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.
Insider Buying and Selling at Danaher
In other news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.
Analysts Set New Price Targets
A number of analysts have weighed in on DHR shares. The Goldman Sachs Group reduced their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Citigroup restated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Wall Street Zen cut shares of Danaher from a "buy" rating to a "hold" rating in a report on Monday, June 9th. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a research report on Friday, March 14th. Finally, HSBC decreased their price target on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and a consensus price target of $248.61.
View Our Latest Analysis on Danaher
Danaher Trading Up 0.6%
NYSE:DHR traded up $1.17 during trading hours on Tuesday, hitting $197.51. The stock had a trading volume of 2,532,682 shares, compared to its average volume of 4,264,437. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The business's 50 day moving average is $193.96 and its 200-day moving average is $209.14. The company has a market cap of $141.35 billion, a price-to-earnings ratio of 38.35, a P/E/G ratio of 2.76 and a beta of 0.77.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio is presently 24.85%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.